Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.
about
SARS: systematic review of treatment effectsRespiratory viruses other than influenza virus: impact and therapeutic advancesManagement of Critically Ill Patients with Severe Acute Respiratory Syndrome (SARS)Antiviral Treatment Guidelines for Middle East Respiratory SyndromeRole of Marine Natural Products in the Genesis of Antiviral AgentsSevere acute respiratory syndrome coronavirus as an agent of emerging and reemerging infectionA review of treatment modalities for Middle East Respiratory Syndrome.Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin.Advances in antivirals for non-influenza respiratory virus infections.Conducting research in disease outbreaks.Severe acute respiratory syndrome (SARS): epidemiology and clinical featuresTreatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaquesThe management of coronavirus infections with particular reference to SARS.Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.Antiviral drugs specific for coronaviruses in preclinical developmentMiddle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like diseaseSevere acute respiratory syndrome (SARS): lessons learnt in Hong KongSevere acute respiratory syndrome (SARS) in neonates and children.Advancements in the battle against severe acute respiratory syndrome.Viral loads in clinical specimens and SARS manifestations.Novel and re-emerging respiratory infections.New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus.Current status of anti-SARS agents.Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndrome.Potential antivirals and antiviral strategies against SARS coronavirus infections.SARS-CoV replication and pathogenesis in an in vitro model of the human conducting airway epitheliumLong-range cooperative interactions modulate dimerization in SARS 3CLpro.Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle.Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital.Inhibition of human coronavirus NL63 infection at early stages of the replication cycle.Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E.Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset.Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice.SARS patients and need for treatment.Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.Prognostication in severe acute respiratory syndrome: a retrospective time-course analysis of 1312 laboratory-confirmed patients in Hong Kong.What are our pharmacotherapeutic options for MERS-CoV?Clinical issues and research in respiratory failure from severe acute respiratory syndrome.Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial.Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
P2860
Q21144696-1EEEDCDF-1266-4F81-BD70-AC7BE07973C9Q24655957-CD889F1B-FC9D-4A00-B3FA-97B0A1A0A1A0Q24791074-29530BD6-6E1C-45F2-AC11-95ED1004AFE9Q26781374-A83AD77B-377E-4B1F-8201-8E42AD0E2743Q26796360-5AE619A8-8F26-4C78-8E75-B6D31B442F1DQ28383088-83A3CE8A-13DE-4E81-ABBC-952DF6F14FF7Q30248209-64E7BC8B-7F00-4B01-8B53-2E813B8F6CFFQ30429521-1820C683-EAA5-47C2-8D65-25B54ECB4046Q30457132-BE26BA0A-261C-4470-9AF7-377405F3D320Q30861999-1EF3A31A-051F-4DF7-B8D1-73E0C81AE8B4Q33361695-5172DEF8-D844-4541-B092-059E1C59E243Q33887877-F6BF17CB-7B6E-4D4C-8264-C28B11C63ACCQ34012358-2204610E-3D54-4A31-9359-3F14B1BD4CB8Q34193942-76B58B0D-2594-43CB-BA59-6CB1E0616D69Q34332580-5EDCF0DD-E86F-460C-A2C0-8EF9BAD00726Q34468689-51EC9616-F53F-4ACE-BDFB-AA87BA4D8A46Q34974298-5C2C337A-D21B-4CBA-AAAA-BC93F35DB133Q35297834-5BBA9A91-80E2-4B66-8E13-69AC6FD5FEE7Q35841566-12E4468E-296E-4C9D-B212-7440C9FFC39AQ35872810-BC732FB6-0978-4AD8-8938-34168036760EQ35917425-10CDED94-7500-4B76-B264-245B9255A5D8Q36058647-A33C5983-D38B-4C2E-AE6F-D947DB46E0EDQ36058652-9425EC93-9955-4C37-A1F7-B32397874C02Q36140676-30DD15BA-B7EC-482C-86EA-FFF814A4A75EQ36441511-26C635C3-9194-4B66-84BD-F17120836CCBQ36658291-3A15C302-D14E-4869-97D3-C61DCE386FD2Q36943869-57DD1B05-4549-4797-9D37-20DB0ACCF79CQ37481314-FAC50379-4678-4877-AB47-38E90863ECB6Q39615623-F8E39AB2-B792-4F7F-92DC-DE8D72166E84Q40275624-8255350E-BF1A-492C-A1D9-530D624E1217Q40429766-8481D7EF-12A7-4416-A3F6-3973FA2004D8Q41096904-B8D5FDE5-2E74-44DF-B68B-CDB707658721Q41943954-919EC94F-7F0F-4498-9FF6-0801A3788210Q42551373-F4A634CA-C047-4F0A-9A22-7A00813E4720Q43280688-57D5F2C2-5075-4E61-8CEB-1E3AC402F124Q44534671-A3009B31-C3D5-4E82-80F7-C95759D854BFQ45006404-6BC655CD-FE70-40F1-8931-F52678FD5B60Q45174339-4658F9B0-48F2-4187-8469-74F44F29DFDEQ47643599-A8BDCFE4-FFE3-4ABE-9006-5DE0AD79B1E1Q50572228-CEF58E59-04FE-40EA-B531-C3FAA6FD10C0
P2860
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Role of lopinavir/ritonavir in ...... logical and clinical findings.
@ast
Role of lopinavir/ritonavir in ...... logical and clinical findings.
@en
type
label
Role of lopinavir/ritonavir in ...... logical and clinical findings.
@ast
Role of lopinavir/ritonavir in ...... logical and clinical findings.
@en
altLabel
Role of lopinavir/ritonavir in ...... ological and clinical findings
@en
prefLabel
Role of lopinavir/ritonavir in ...... logical and clinical findings.
@ast
Role of lopinavir/ritonavir in ...... logical and clinical findings.
@en
P2093
P2860
P50
P921
P1433
P1476
Role of lopinavir/ritonavir in ...... ological and clinical findings
@en
P2093
C L P Wong
HKU/UCH SARS Study Group
M M L Wong
V C C Cheng
P2860
P304
P356
10.1136/THORAX.2003.012658
P407
P5008
P577
2004-03-01T00:00:00Z